Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A mutant KRAS‐induced factor REG4 promotes cancer stem cell properties via Wnt/β‐catenin signaling
Jeongha Hwang, Junyong Yoon, Yong‐Hee Cho, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 10, pp. 2877-2890
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
Huimin Zhang, Chunhong Qin, Changming An, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 167
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis
Xiaobo Zheng, Jinen Song, Chune Yu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Single-cell RNA sequencing and machine learning provide candidate drugs against drug-tolerant persister cells in colorectal cancer
Yosui Nojima, Ryoji Yao, Takashi Suzuki
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167693-167693
Closed Access | Times Cited: 1
Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases
Mansoor Bolideei, Rambod Barzigar, Razieh Bahrami Gahrouei, et al.
Stem Cell Reviews and Reports (2025)
Closed Access | Times Cited: 1
The importance of Ras in drug resistance in cancer
Fiona Healy, Ian A. Prior, David J. MacEwan
British Journal of Pharmacology (2021) Vol. 179, Iss. 12, pp. 2844-2867
Open Access | Times Cited: 43
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 5531-5559
Open Access | Times Cited: 16
KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
Koushik Mondal, Mahesh Kumar Posa, Revathi P Shenoy, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1221-1221
Open Access | Times Cited: 7
The effects of mutant Ras proteins on the cell signalome
Tamás Takács, Gyöngyi Kudlik, Anita Kurilla, et al.
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 4, pp. 1051-1065
Open Access | Times Cited: 49
miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression
Longyang Liu, Yingxia Ning, Juanjuan Yi, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 125, pp. 109865-109865
Open Access | Times Cited: 48
Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology
Loretta László, Anita Kurilla, Tamás Takács, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 667-667
Open Access | Times Cited: 38
Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in ApcS580/+; KrasG12D/+ Mice
Huajun Han, Laurie A. Davidson, Martha E. Hensel, et al.
Molecular Cancer Research (2021) Vol. 19, Iss. 5, pp. 771-783
Open Access | Times Cited: 35
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1
Palanivel Kandasamy, Inti Zlobec, Damian T. Nydegger, et al.
Molecular Oncology (2021) Vol. 15, Iss. 10, pp. 2782-2800
Open Access | Times Cited: 34
REG4 promotes the proliferation and anti-apoptosis of cancer
Hua‐chuan Zheng, Hang Xue, Congyu Zhang
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 23
Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination
Mojgan Barati, Maryam Akhondi, Narges Sabahi Mousavi, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 6, pp. 1975-1992
Open Access | Times Cited: 30
Lung Cancer Stem Cells—Origin, Diagnostic Techniques and Perspective for Therapies
Agata Raniszewska, Iwona Kwiecień, Elżbieta Rutkowska, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2996-2996
Open Access | Times Cited: 27
A review on applications and safety of 222 nm far UVC light for surface and air disinfection
Kimia Ghasemi Arzanani, M. Vaziri, Samaneh Sharif, et al.
Biophysical Reviews (2025)
Closed Access
Intracellular Delivery of Anti-Kirsten Rat Sarcoma Antibodies Mediated by Polymeric Micelles Exerts Strong In Vitro and In Vivo Anti-Tumorigenic Activity in Kirsten Rat Sarcoma-Mutated Cancers
Diana Rafael, Sara Montero‐Herradón, Pilar Carcavilla, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10398-10413
Closed Access | Times Cited: 9
SCF‐FBXL8 contributes to liver metastasis and stem‐cell‐like features in colorectal cancer cells by mediating ubiquitination and degradation of TP53
Jing Yao, Xin‐Ping Wang, H. J. Yang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 8
Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling
Wai‐Hung Leung, Jing-Wen Shih, Jian-Syun Chen, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 377-377
Open Access | Times Cited: 11
The molecular features of lung cancer stem cells (LCSCs) in dedifferentiation process-driven epigenetic alterations
Valentina Masciale, Federico Banchelli, Giulia Grisendi, et al.
Journal of Biological Chemistry (2024), pp. 107994-107994
Open Access | Times Cited: 2
Promotion of cancer cell stemness by Ras
Rohan Chippalkatti, Daniel Abankwa
Biochemical Society Transactions (2021) Vol. 49, Iss. 1, pp. 467-476
Open Access | Times Cited: 15
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
Kshama Gupta, Jeremy Jones, Virgínea Farias, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
The Clinical Significance and Mechanisms of REG4 in Human Cancers
Junyan Zhang, Zhi Zhu, Zhi‐Feng Miao, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 14
The effects of REG4 expression on chemoresistance of ovarian cancer
Liwei Xiang, Hang Xue, Min-Wen Ha, et al.
Journal of Obstetrics and Gynaecology (2022) Vol. 42, Iss. 7, pp. 3149-3157
Closed Access | Times Cited: 9
Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly
Congyu Zhang, Rui Zhang, Zhang Li, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 35, pp. 5104-5124
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top